CD4 Lymphocyte CountHIV InfectionsAntiretroviral Therapy, Highly ActiveAnti-HIV AgentsViral LoadCD4-CD8 RatioAnti-Retroviral AgentsAntigens, CD8Antigens, CD3HIV-1CD40 LigandCD4-Positive T-LymphocytesNevirapineAntigens, CD40South AfricaAntigens, CD34Antigens, CD44Antigens, CD28Cohort StudiesTreatment OutcomeLeukocyte CountBotswanaAntigens, CD14Acquired Immunodeficiency SyndromeAntigens, CD38HIVTime FactorsAIDS-Related Opportunistic InfectionsAntigens, CD1Antigens, CD80RNA, ViralFollow-Up StudiesPlatelet CountDrug Therapy, CombinationAntigens, CD2BenzoxazinesAntigens, CD19Prospective StudiesAntigens, CDAntigens, CD86Antigens, CD95Drug Administration ScheduleLost to Follow-UpAntigens, CD5StavudineAntigens, CD18Antigens, CD56Disease ProgressionRitonavirUgandaRetrospective StudiesIndinavirAntigens, CD30Risk FactorsHIV Protease InhibitorsLongitudinal StudiesAntigens, CD24Reverse Transcriptase InhibitorsAntigens, CD36LopinavirAntigens, CD9Treatment FailureViremiaHIV SeropositivityCD8-Positive T-LymphocytesAntigens, CD20Antigens, CD7Cell CountTuberculosisAntigens, CD43Proportional Hazards ModelsLamivudineAntigens, CD11ZidovudineAntigens, CD47Antigens, CD59Blood Cell CountAntigens, CD70Antigens, CD46Antigens, CD11bMultivariate AnalysisAntigens, CD57Lymphocyte CountMedication AdherenceIncidenceAntigens, CD81Antigens, CD31Antigens, CD137CD30 LigandAntigens, CD11cAntigens, CD151Antigens, CD55Antigens, CD58Survival AnalysisAntigens, CD63Colony Count, MicrobialHepatitis CAntigens, CD13Antigens, CD11aErythrocyte Count